• An Early-Stage THx, Dx & Device Focus:

    Welcome to the site formerly known as [Colorado] Life Science Deal Flow. This new version looks at the biopharma world primarily from an early-stage financing perspective. Be certain to visit our companion site, a FREE Venture Capital dBase, OnBioVC.com, and subscribe by email or RSS.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

Two beautiful new Colorado websites can be found…
Taligen Therapeutics, Inc., new website (here), is a development stage biotechnology company with a novel technology to modulate and regulate activation of the complement system. An IND for their lead product, TA106 for persistent asthma, should hopefully be filed by 4Q07.
And at 578 acres, the Fitzsimons Life Science [...]

Slicing and dicing some of the data contained in the Ernst and Young 2006 Beyond Borders Biotech report reveals how Colorado is faring as a snapshot relative to the total U.S. Biotech Market:

U.S. Total Public CO’s
336

Colorado Public CO’s
6

U.S. Total Market Cap
$ 392,400,000,000

Colorado Market Cap
$ [...]

Reflecting back upon my first BIO conference the experience bordered on overwhelming yet yielded a new understanding that this event is now to be filed under mandatory attendance for the coming years.
Overwhelming in the sense that there were simply not enough hours in the day to attend all of the seminars of interest, connect [...]

I can not believe it has been two years since I stumbled into this blogging thing. Needless to say how rewarding it has been, just wish there was more time to allocate to posting. In year 3 I hope to derive a more consistent content output protocol.
A present to myself is to spruce up the [...]

BaroFold is raising a $12M Series A to be co-led by HBM BioVentures and Boulder Ventures and will be joined by the Peierls Foundation and other seed investors.
BaroFold has developed and patented a protein processing technology that employs hydrostatic pressure to disaggregate and refold recombinant proteins from aggregates and inclusion bodies. The PreEMT™ process refolds [...]

I was intrigued by the title of this morning’s business development tract – Risky Business: Risk Reduced Models for the Biotech Industry – so I jumped ship from my finance focus and was not disappointed. What a lively and interesting dialogue by the CEO panelists (Steve Kelly – Innovive Pharma, Scott Cormack – OncoGeneX, Jay [...]

Now here is a uniquely fantastic program…the Biomedical Enterprise Program is jointly administered by the Harvard-MIT Division of Health Sciences and Technology and the MIT Sloan School of Management, it exposes students to an integrated curriculum focused on the complex process of product development and commercialization in the health care industry.
Today I met some great [...]

What an action packed day. I live, eat and breathe in the world of seed-stage start-ups via my work with the Fitzsimons BioBusiness Incubator. Achieving a first institutional round (i.e. VC, PE or IB) financing is what we are constantly striving for, thus I found myself immersed in the finance tract for the morning, first [...]

Had a blast today. Got registered. (Thanx to Doug Schulz BIO2007 Web Team Director who had me upgraded to full media credentials and naturally thanx to the Colorado BioScience Association and the Fitzsimons Life Science District for the invite). Started out at the Media Brunch for a comparison of an insiders’ view of the industry [...]

Arrived in Boston, well actually I am couch surfing in Cambridge. Could not be more excited to get going. Unfortunately the Cambridge BioBus and Human Genome Trail tour has been canceled. Disappointed about that but what can you do. Instead I will get registered and already have my first meeting slated for Sunday afternoon. If [...]

NOTE: This Post Comes From BIO Voice, Blog of the BIO2007 Convention
With still a few days to go before BIO2007 officially kicks off I am already impressed with the convention. Naturally I am ecstatic that BIO2007 has embraced the blog and I have been asked to participate! I love all of the functionality that [...]

AlphaSniffer, LLC (Boulder) was founded in 2003 by Dr. Misha Plam. AlphaSniffer has developed a highly-sensitive biosensor for the detection of trace amounts (picograms) of bacteria, viruses, proteins, nucleic acids, antibodies and other biological and chemical agents in real-time and with minimal human intervention. Dr. Plam is the former founder, CEO, President and Chairman of [...]

  

to top of page...


 
  • The Latest LSDF Activity

    May 2007
    M T W T F S S
    « Apr   Jun »
    123456
    78910111213
    14151617181920
    21222324252627
    282930  
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com